295 related articles for article (PubMed ID: 27229642)
21. A plea for personalization of the hemodynamic management of septic shock.
De Backer D; Cecconi M; Chew MS; Hajjar L; Monnet X; Ospina-Tascón GA; Ostermann M; Pinsky MR; Vincent JL
Crit Care; 2022 Dec; 26(1):372. PubMed ID: 36457089
[TBL] [Abstract][Full Text] [Related]
22. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
Carr AC; Shaw GM; Fowler AA; Natarajan R
Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
[TBL] [Abstract][Full Text] [Related]
23. [Value of pulse indicator continuous cardiac output monitoring of cardiac function in septic shock patients: a prospective study].
Yi M; Yao G; Guo X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):22-7. PubMed ID: 25591432
[TBL] [Abstract][Full Text] [Related]
24. [Adherence to international guidelines on early management in severe sepsis and septic shock].
Quintero RA; Martínez CA; Gamba JD; Ortiz I; Jaimes F
Biomedica; 2012 Sep; 32(3):449-56. PubMed ID: 23715193
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic support during sepsis.
Ognibene FP
Clin Chest Med; 1996 Jun; 17(2):279-87. PubMed ID: 8792066
[TBL] [Abstract][Full Text] [Related]
26. Updates in Sepsis Resuscitation.
Ellender T; Benzoni N
Emerg Med Clin North Am; 2020 Nov; 38(4):807-818. PubMed ID: 32981619
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Perfusion Index as a Predictor of Vasopressor Requirement in Patients with Severe Sepsis.
Rasmy I; Mohamed H; Nabil N; Abdalah S; Hasanin A; Eladawy A; Ahmed M; Mukhtar A
Shock; 2015 Dec; 44(6):554-9. PubMed ID: 26529657
[TBL] [Abstract][Full Text] [Related]
28. The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials.
Al Sulaiman K; Alkofide HA; AlFaifi ME; Aljohani SS; Al Harthi AF; Alqahtani RA; Alanazi AM; Nazer LH; Al Shaya AI; Aljuhani O
Saudi Pharm J; 2024 Jun; 32(6):102094. PubMed ID: 38812943
[TBL] [Abstract][Full Text] [Related]
29. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
Oba Y; Lone NA
J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
[TBL] [Abstract][Full Text] [Related]
30. [The new aspects of treatment of severe sepsis and septic shock].
Adukauskiene D; Rimdeika R; Vitkauskiene A; Pilvinis V; Cicinskaite I
Medicina (Kaunas); 2006; 42(4):265-72. PubMed ID: 16687897
[TBL] [Abstract][Full Text] [Related]
31. [Current concepts on hemodynamic support and therapy in septic shock].
Rocha LL; Pessoa CM; Corrêa TD; Pereira AJ; de Assunção MS; Silva E
Rev Bras Anestesiol; 2015; 65(5):395-402. PubMed ID: 26296982
[TBL] [Abstract][Full Text] [Related]
32. Shock - Classification and Pathophysiological Principles of Therapeutics.
Kislitsina ON; Rich JD; Wilcox JE; Pham DT; Churyla A; Vorovich EB; Ghafourian K; Yancy CW
Curr Cardiol Rev; 2019; 15(2):102-113. PubMed ID: 30543176
[TBL] [Abstract][Full Text] [Related]
33. Current concepts on hemodynamic support and therapy in septic shock.
Rocha LL; Pessoa CM; Corrêa TD; Pereira AJ; de Assunção MS; Silva E
Braz J Anesthesiol; 2015; 65(5):395-402. PubMed ID: 26323739
[TBL] [Abstract][Full Text] [Related]
34. Vasopressor weaning in patients with septic shock.
Arellano DL; Hanneman SK
Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
[TBL] [Abstract][Full Text] [Related]
35. An international survey of adherence to Surviving Sepsis Campaign Guidelines 2016 regarding fluid resuscitation and vasopressors in the initial management of septic shock.
Bitton E; Zimmerman S; Azevedo LCP; Benhamou D; Cecconi M; De Waele JJ; Lipman J; Martin-Loeches I; Pirracchio R; Scheeren TWL; Leone M; Einav S
J Crit Care; 2022 Apr; 68():144-154. PubMed ID: 34895959
[TBL] [Abstract][Full Text] [Related]
36. Microvascular resuscitation as a therapeutic goal in severe sepsis.
Bateman RM; Walley KR
Crit Care; 2005; 9 Suppl 4(Suppl 4):S27-32. PubMed ID: 16168071
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II in Refractory Septic Shock.
Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive Agents for Adult Septic Shock: An Update and Review.
Dalimonte MA; DeGrado JR; Anger KE
J Pharm Pract; 2020 Aug; 33(4):523-532. PubMed ID: 31057085
[TBL] [Abstract][Full Text] [Related]
39. Vasopressor use in adult patients.
Ferguson-Myrthil N
Cardiol Rev; 2012; 20(3):153-8. PubMed ID: 22318007
[TBL] [Abstract][Full Text] [Related]
40. Vasoactive drugs for vasodilatory shock in ICU.
Holmes CL; Walley KR
Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
